Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Recordati Rare Diseases, Immeuble Le Wilson, 70 avenue du Général de Gaulle, 92800 Puteaux, France
COSMEGEN LYOVAC 500 micrograms powder for solution for injection.
| Pharmaceutical Form |
|---|
|
Lyophilised powder for solution for injection. |
Cosmegen Lyovac is supplied as a yellow-orange, lyophilised powder, in a vial containing 500 micrograms dactinomycin with 20 mg mannitol E421.
| Active Ingredient | Description | |
|---|---|---|
| Dactinomycin |
Dactinomycin is an antineoplastic antibiotic derived from Streptomyces parvullus. Stable complexes are formed with DNA through intercalation and DNA-dependent RNA synthesis is selectively inhibited. Protein and DNA synthesis are inhibited to a lesser extent. |
| List of Excipients |
|---|
|
Mannitol E421 |
Glass vials containing 500 micrograms dactinomycin with 20 mg mannitol.
Recordati Rare Diseases, Immeuble Le Wilson, 70 avenue du Général de Gaulle, 92800 Puteaux, France
PL 15266/0018
Date of grant at last renewal: 12 July 2006
| Drug | Countries | |
|---|---|---|
| COSMEGEN | Canada, Estonia, France, Japan, Malta, New Zealand, Romania, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
